Pfizer Global Medical Grants: Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel Diseases – RFP

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: inquire with unit

Memorial Deadline: Wednesday 13th, July 2022

External Deadline: Monday 18th, July 2022


Description

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.

Geographic Scope: Canada

Clinical Area: Inflammatory Bowel Disease (IBD) and Mental Health

Link to full RFP: Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel Diseases

Application Due Date: July 18, 2022

Specific Area of Interest: Quality improvement (QI) Projects that will be considered for Pfizer support will focus on improving the care of patients affected by Mental Health Issues and Inflammatory Bowel Diseases through the implementation of innovative solutions aimed at:

  • – Improving the referral and flow process of patients to medical centers
  • – Supporting collaboration among health care providers within a multidisciplinary team environment to improve patient management
  • – Improving treatment adherence
    – Implementing health care technologies (mobile or web-based tools) for telehealth and remote monitoring

Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Sarthak Pandit, Grant Officer (sarthak.pandit@pfizer.com).


Funding Sources

Pfizer Inc



This opportunity was posted by: RGCS

Last modified: June 6, 2022